Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer observatory: cancer today [Internet]. International Agency for Research on Cancer. 2020. https://gco.iarc.fr/today.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–31.
Association of the Nordic Cancer Registries. NORDCAN [Internet]. 2023. https://nordcan.iarc.fr/en.
Youlden DR, Baade PD, Green AC, Valery PC, Moore AS, Aitken JF. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Med J Aust. 2020;212:113–20.
Ostrom QT, Fahmideh MA, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21:1357–75.
Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, et al. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomark Prev. 2014;23:2716–36.
Ostrom QT, Francis SS, Barnholtz-Sloan JS. Epidemiology of brain and other CNS tumors. Curr Neurol Neurosci Rep. 2021;21:1–12.
Leong C, Chateau D, Dahl M, Falk J, Katz A, Bugden S, et al. Prescription medication use during pregnancies that resulted in births and abortions (2001-2013): a retrospective population-based study in a Canadian population. PLoS ONE. 2019;14:e0211319.
Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;1:e1–8.
Brender JD, Kelley KE, Werler MM, Langlois PH, Suarez L, Canfield MA. Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy. Birth Defects Res A Clin Mol Teratol. 2011;91:258–64.
Schüz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr. 2007;166:433–41.
Momen NC, Olsen J, Gissler M, Kieler H, Haglund B, Li J. Exposure to systemic antibacterial medications during pregnancy and risk of childhood cancer. Pharmacoepidemiol Drug Saf. 2015;24:821–9.
Bonaventure A, Simpson J, Ansell P, Roman E, Lightfoot T. Prescription drug use during pregnancy and risk of childhood cancer—is there an association. Cancer Epidemiol. 2015;39:73–8.
Fitton CA, Steiner MFC, Aucott L, Pell JP, Mackay DF, Fleming M, et al. In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017;35:2123–37.
Lydakis C, Lip GYH, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999;12:541–7.
Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, et al. Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry. 2020;77:1246–55.
Tanoshima M, Kobayashi T, Tanoshima R, Beyene J, Koren G, Ito S. Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis. Clin Pharm Ther. 2015;98:417–41.
Fan H, Gilbert R, O’Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ. 2020;368:m766.
Fan H, Li L, Wijlaars L, Gilbert RE. Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: a systematic review and meta-analysis. PLoS ONE. 2019;14:e0212212.
Vuong AM, Shinde MU, Brender JD, Shipp EM, Huber JC, Sharkey JR, et al. Prenatal exposure to nitrosatable drugs, dietary intake of nitrites, and preterm birth. Am J Epidemiol. 2016;183:634–42.
Cardy AH, Little J, McKean-Cowdin R, Lijinsky W, Choi NW, Cordier S, et al. Maternal medication use and the risk of brain tumors in the offspring: The SEARCH international case-control study. Int J Cancer. 2006;118:1302–8.
Connelly JM, Malkin MG. Environmental risk factors for brain tumors. Curr Neurol Neurosci Rep. 2007;7:208–14.
Hjorth S, Hemmingsen CH, Bénévent J, Broe A, Pottegaard A, Mørch LS, et al. Maternal medication use and childhood cancer in offspring—systematic review and considerations for researchers. Am J Epidemiol. 2021;190:2487–99.
Preston-Martin S, Yu MC, Benton B, Henderson BE. N-nitroso compounds and childhood brain tumors: a case-control study. Cancer Res. 1982;42:5240–5.
Cahoon EK, Inskip PD, Gridley G, Brenner AV. Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. Br J Cancer. 2014;110:1825–33.
Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Kheifets L. Birth weight and other perinatal factors and childhood CNS tumors: a case-control study in California. Cancer Epidemiol. 2013;37:402–9.
Volkova A, Ruggles K, Schulfer A, Gao Z, Ginsberg SD, Blaser MJ. Effects of early-life penicillin exposure on the gut microbiome and frontal cortex and amygdala gene expression. iScience. 2021;24:102797.
Howe GR, Burch JD, Chiarelli AM, Risch HA, Choi BCK. An exploratory case-control study of brain tumors in children. Cancer Res. 1989;49:4349–52.
Gumey JG, Mueller BA, Preston-Martin S, Mc Daniel AM, Holly EA, Pogoda JM, et al. A study of pediatric brain tumors and their association with epilepsy and anticonvulsant use. Neuroepidemiology. 1997;16:248–55.
Goldhaber MK, Selby JV, Hiatt RA, Quesenberry CP. Exposure to barbiturates in utero and during childhood and risk of intracranial and spinal cord tumors. Cancer Res. 1990;50:4600–3.
Cordier S, Iglesias M‐J, Le Goaster C, Guyot M‐M, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. Int J cancer. 1994;59:776–82.
Olsen JH, Boice JD, Jensen JPA, Fraumeni JF. Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst. 1989;81:803–9.
Cheng S, McLaughlin JR, Brown MC, Al-Sawaihey H, Rutka J, Bouffet E, et al. Childhood head trauma and the risk of childhood brain tumours: a case-control study in Ontario, Canada. Int J Cancer. 2021;150:795–801.
Yanik EL, Smith JM, Shiels MS, Clarke CA, Lynch CF, Kahn AR, et al. Cancer risk after pediatric solid organ transplantation. Pediatrics. 2017;139:20163893.
Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, et al. The evolutionary history of 2,658 cancers. Nature. 2020;578:122–8.
Zhang Y, Chen F, Donehower LA, Scheurer ME, Creighton CJ. A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement. Nat Commun. 2021;12:937.
Ullrich NJ, Pomeroy SL, Kapur K, Manley PE, Goumnerova LC, Loddenkemper T. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. 2015;56:1599–604.
Sánchez Fernández I, Loddenkemper T. Seizures caused by brain tumors in children. Seizure. 2017;44:98–107.
Salminen J, Tammela T, Auvinen A, Murtola T. Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case-control study. Cancer Causes Control. 2016;27:637–45.
Singh G, Driever PH, Sander JW. Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 2005;128:7–17.
Günaldi M, Paydaş S, Afşar ÇU, Duman BB, Erçolak V, Haksöyler V. Karbamazepin ve multipl miyelom: Olasi i̇lişki. Turkish J Hematol. 2013;30:83–4.
Kristensen KB, Pedersen SA, Schmidt SAJ, Pottegård A. Use of antiepileptic drugs and risk of skin cancer: a nationwide case-control study. J Am Acad Dermatol. 2020;82:326–35.
Stritzelberger J, Lang JD, Mueller TM, Reindl C, Westermayer V, Kostev K, et al. Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients. J Neurol. 2021;268:2185–91.
Kim H-B, Myung S-K, Park YC, Park B. Use of benzodiazepine and risk of cancer: a meta-analysis of observational studies. Int J Cancer. 2017;140:513–25.
Miyawaki I, Moriyasu M, Funabashi H, Yasuba M, Matsuoka N. Mechanism of clobazam-induced thyroidal oncogenesis in male rats. Toxicol Lett. 2003;145:291–301.
McCredie M, Maisonneuve P, Boyle P. Antenatal risk factors for malignant brain tumours in new south wales children. Int J Cancer. 1994;56:6–10.
Stålberg K, Haglund B, Strömberg B, Kieler H. Prenatal exposure to medicines and the risk of childhood brain tumor. Cancer Epidemiol. 2010;34:400–4.
Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, et al. Paracetamol use during pregnancy — a call for precautionary action. Nat Rev Endocrinol. 2021;17;757–766.
Kramer S, Ward E, Meadows A, Malone K. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst. 1987;78:797–804.
Momen NC, Munk-Olsen T, Li J, Ingstrup KG, Olsen J, Bergink V, et al. Antidepressant use during pregnancy and childhood cancer in the offspring. Pharmacoepidemiol Drug Saf. 2018;27:114–8.
Centers for Disease Control and Prevention (CDC). Prevalence of self-reported epilepsy—United States, 1986–1990. JAMA. 1994;272:1893.
Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:821–5.
Hales CM, Kit BK, Gu Q, Ogden CL. Trends in prescription medication use among children and adolescents-United States, 1999-2014. J Am Med Assoc. 2018;319:2009–20.